HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $355,000 | +14.5% | 20,000 | 0.0% | 0.01% | +8.3% |
Q3 2019 | $310,000 | -9.9% | 20,000 | 0.0% | 0.01% | -7.7% |
Q2 2019 | $344,000 | +6.8% | 20,000 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $322,000 | +9.9% | 20,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $293,000 | -90.5% | 20,000 | -88.2% | 0.01% | -87.0% |
Q3 2018 | $3,089,000 | +7.7% | 170,000 | 0.0% | 0.10% | -6.5% |
Q2 2018 | $2,868,000 | -13.9% | 170,000 | 0.0% | 0.11% | -23.0% |
Q1 2018 | $3,330,000 | -3.3% | 170,000 | 0.0% | 0.14% | -5.4% |
Q4 2017 | $3,444,000 | +16.6% | 170,000 | 0.0% | 0.15% | +15.7% |
Q3 2017 | $2,953,000 | -75.7% | 170,000 | -82.1% | 0.13% | -74.3% |
Q2 2017 | $12,176,000 | – | 949,800 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |